Patent Application: Highly Porous Max Phase Precursor For MXene
Inventors: Yury Gogotsi, Oleksiy Gogotsi, Iryna Roslyk, Veronika Zahorodna, Ivan Baginskiy, Robert Lord
Publication number: 20250136452
Publication date: May 1, 2025
Technical field: The present disclosure relates to the field of material science and to the fields of MAX-phase and MXene materials.
Abstract: A method, comprising: forming a porous MAX-phase material. A MAX-phase material, the MAX-phase material made according to the present disclosure. A MXene material, the MXene material formed by removal of the A-group element of a MAX-phase material made according to the present disclosure.
Type: Application
Filed: October 18, 2024
Publication date: May 1, 2025
Background: Since MXenes' discovery, obtaining porous MAX phase precursors, such as Ti3AlC2, for the synthesis of MXenes, such as Ti3C2, became an important task. The low-density MAX phase can be crushed into powder with little force and without extensive milling. This not only decreases the cost of manufacturing, but also avoids lattice distortion of the MAX phase and produces a higher quality MXene. Conventionally, MAX phases are produced by hot pressing, hot isostatic pressing, or pressureless sintering, as they were developed for structural applications requiring dense and mechanically strong materials. All those methods lead to hard and strong sintered bodies that require crushing and high-energy milling to produce a powder. A traditional approach to manufacturing porous Ti—Al—C and some other ceramics is to add different additives in the mixture such as NaCl that prevent complete sintering and can be removed during or after processing. However, any addition to the mixture can lead to contamination of the MAX phase and MXenes, as well as affect the stoichiometry, purity, and properties of the materials.
In this work we have optimized the synthesis of MAX phases for MXene manufacturing. The main purpose was to develop a porous Ti3AlC2MAX phase that can be easily ground into individual grains manually without time-consuming eliminating the need for drilling and intenseball-milling before MXene synthesis. Moreover, we also demonstrate the synthesis of highly porous Ti3AlC2 (about 70%) from an inexpensive raw materials.
Read more about this work:
Our new collaborative research paper with Drexel team on Porous Ti3AlC2 MAX phase enables efficient synthesis of Ti3C2Tx MXene
The main purpose of this study is to develop a porous Ti3AlC2MAX phase that can be easily ground into individual grains manually without time-consuming eliminating the need for drilling and intenseball-milling before MXene synthesis. Moreover, we also demonstrate the synthesis of highly porous Ti3AlC2 (about 70%) from an inexpensive raw materials.
#MAX-phase #MXenes #Patent
MXenes potential applications include sensors, wound healing materials, and drug delivery systems. A recent study explored how different synthesis methods affect the safety and performance of MXenes. By comparing etching conditions and intercalation strategies, researchers discovered that fine-tuning the surface chemistry of MXenes plays a crucial role in improving biocompatibility. These results provide practical guidelines for developing safer MXenes and bring the field one step closer to real biomedical applications.
Last Call! Have you submitted your abstract for IEEE NAP-2025 yet? Join us at the International Symposium on "The MXene Frontier: Transformative Nanomaterials Shaping the Future" – the largest MXene-focused conference in Europe this year! Final Submission Deadline: May 15, 2025. Don’t miss this exclusive opportunity to showcase your research and engage with world leaders in the MXene field!
We are excited to announce the publication of latest review article on MXenes in Healthcare. This comprehensive review explores the groundbreaking role of MXenes—an emerging class of 2D materials—in revolutionizing the fields of medical diagnostics and therapeutics. Read the full article here: https://doi.org/10.1039/D4NR04853A.
Congratulations and thank you to our collaborators from TU Wien and CEST for very interesting work and making it published! In this work, an upscalable electrochemical MXene synthesis is presented. Yields of up to 60% electrochemical MXene (EC-MXene) with no byproducts from a single exfoliation cycle are achieved.
Congratulations to all collaborators with this interesting joint work!
Thank you to our collaborators for the amazing joint work recently published in Graphene and 2D Nanomaterials about MXene–silk fibroin composite films aiming to develop materials with tunable electronic and thermal properties
Dr. Oleksiy Gogotsi, director of MRC and Carbon-Ukraine, innovative companies that are among the leaders on the world MXene market, visited 2024 MRS Fall Meeting & Exhibit. together with Dr. Maksym Pogorielov, Head of Advanced Biomaterials and Biophysics Laboratory, University of Latvia.
MRC and Carbon-Ukraine team visited the 3rd International MXene conference held at Drexel University on August 5-8, 2024. Conference brought together the best reserchers and leading experts on MXene field. 
Together with colleagues from the University of Latvia, MRC/Carbone Ukraine, Adam Mickiewicz University, University Clinic Essen, and others, we have developed a novel concept involving the binding of antibodies to MXenes. In our research, we utilized anti-CEACAM1 antibodies to develop targeted photo-thermal therapy for melanoma (in vitro), paving the way for future in vivo studies and clinical trials. For the first time, we demonstrate the feasibility of delivering MXenes specifically targeted to melanoma cells, enabling the effective ablation of cancer cells under near-infrared (NIR) light. This new technique opens up vast potential for the application of MXenes in cancer treatment, diagnostics, drug delivery, and many other medical purposes.